Development of a novel immunoassay for the iron regulatory peptide hepcidin

被引：62

作者：

Busbridge, M. ^{[1
]}

Griffiths, C. ^{[1
]}

Ashby, D. ^{[2
]}

Gale, D. ^{[3
]}

Jayantha, A. ^{[4
]}

Sanwaiya, A. ^{[4
]}

Chapman, R. S. ^{[1
]}

机构：

[1] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Clin Biochem, London W6 8RF, England

[2] Univ London Imperial Coll Sci Technol & Med, Kidney & Transplant Inst, Imperial Coll Healthcare NHS Trust, London, England

[3] UCL, Div Med, London, England

[4] Ealing Hosp NHS Trust, Dept Gastroenterol, London, England

来源：

BRITISH JOURNAL OF BIOMEDICAL SCIENCE | 2009年 / 66卷 / 03期

基金：

英国医学研究理事会;

关键词：

Ferritins; Hepcidin; Immunoassay; HEREDITARY HEMOCHROMATOSIS; DEFICIENCY ANEMIA; SERINE-PROTEASE; TMPRSS6; GENE; SERUM; INFLAMMATION; MUTATIONS; LIVER; FERROPORTIN; URINE;

D O I：

10.1080/09674845.2009.11730263

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

To date there have been few published immunoassays for the important iron regulator hepcidin. This study describes a novel competitive radioimmunoassay (RIA) for the bioactive hepcidin peptide. A rabbit anti-hepcidin polyclonal antibody was produced using synthetic hepcidin radiolabelled with I-125 to produce a competitive RIA. Normal patient (n=47) samples were collected and assayed for hepcidin to determine a reference range. Other patient groups collected were ulcerative colitis (UC; n=40), iron deficiency anaemia (IDA; n=15), chronic kidney disease not requiring dialysis (CKD; n=45) and chronic kidney disease requiring dialysis (HCKD; n = 94). Detection limit of the assay was determined as 0.6 ng/mL. Intra-assay precision was 5 ng/mL (7.2%) and 50 ng/mL (5.8%), inter-assay precision was 5 ng/mL (7.6%) and 50 ng/mL (6.7%). Analytical recovery was 98% (5 ng/mL), 94% (10 ng/mL) and 97% (50 ng/mL). The assay was linear up to 200 ng/mL. No demonstrable cross-reactivity with human insulin, glucagon I, angiotensinogen I, beta-defensin 1-4, alpha-defensin-1 and plectasin was observed. There was significant correlation (r=0.96, P <= 0.0001) between the hepcidin RIA and an established hepcidin SELDI-TOF-MS method. Analysis of the normal human samples gave a reference range of 1.1-55 ng/mL for hepcidin. Further statistical evaluation revealed a significant difference between male and female hepcidin levels. There was significant correlation between hepcidin and ferritin in the control group (r=0.6, P <= 0.0001). There was also a significant difference between the normal and disease groups (P <= 0.0001). Healthy volunteers (n=10) showed a diurnal increase in plasma hepcidin at 4.00 pm compared to 8.00 am. A robust and optimised immunoassay for bioactive hepcidin has been produced and the patient sample results obtained further validates the important role of hepcidin in iron regulation, and will allow further investigation of this important peptide and its role in iron homeostasis.

引用

页码：150 / 157

页数：8

共 28 条

[1] The serine protease TMPRSS6 is required to sense iron deficiency [J].

Du, Xin ;

She, Ellen ;

Gelbart, Terri ;

Truksa, Jaroslav ;

Lee, Pauline ;

Xia, Yu ;

Khovananth, Kevin ;

Mudd, Suzanne ;

Mann, Navjiwan ;

Moresco, Eva Marie Y. ;

Beutler, Ernest ;

Beutler, Bruce .

SCIENCE, 2008, 320 (5879) :1088-1092

[2] Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) [J].

Finberg, Karin E. ;

Heeney, Matthew M. ;

Campagna, Dean R. ;

Aydinok, Yesim ;

Pearson, Howard A. ;

Hartman, Kip R. ;

Mayo, Mary M. ;

Samuel, Stewart M. ;

Strouse, John J. ;

Markianos, Kyriacos ;

Andrews, Nancy C. ;

Fleming, Mark D. .

NATURE GENETICS, 2008, 40 (05) :569-571

[3] Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease [J].

Fleming, RE ;

Sly, WS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) :8160-8162

[4] Hepcidin in iron metabolism [J].

Ganz, T .

CURRENT OPINION IN HEMATOLOGY, 2004, 11 (04) :251-254

[5] Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency [J].

Guillem, Flavia ;

Lawson, Sarah ;

Kannengiesser, Caroline ;

Westerman, Mark ;

Beaurnont, Carole ;

Grandchamp, Bernard .

BLOOD, 2008, 112 (05) :2089-2091

[6] Novel urine hepcidin assay by mass spectrometry [J].

Kemna, E ;

Tjalsma, H ;

Laarakkers, C ;

Nemeth, E ;

Willems, H ;

Swinkels, D .

BLOOD, 2005, 106 (09) :3268-3270

[7] Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS [J].

Kemna, E ;

Pickkers, P ;

Nemeth, E ;

van der Hoeven, H ;

Swinkels, D .

BLOOD, 2005, 106 (05) :1864-1866

[8] Mass spectrometry-based hepcidin measurements in serum and urine: Analytical aspects and clinical implications [J].

Kemna, Erwin H. J. M. ;

Tjalsma, Harold ;

Podust, Vladimir N. ;

Swinkels, Dorine W. .

CLINICAL CHEMISTRY, 2007, 53 (04) :620-628

[9] LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity [J].

Krause, A ;

Neitz, S ;

Mägert, HJ ;

Schulz, A ;

Forssmann, WG ;

Schulz-Knappe, P ;

Adermann, K .

FEBS LETTERS, 2000, 480 (2-3) :147-150

[10] Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia [J].

Kulaksiz, H ;

Gehrke, SG ;

Janetzko, A ;

Rost, D ;

Bruckner, T ;

Kallinowski, B ;

Stremmel, W .

GUT, 2004, 53 (05) :735-743

← 1 2 3 →